Skip to content

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients: A Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06952361
Enrollment
107
Registered
2025-04-30
Start date
2019-03-08
Completion date
2021-11-24
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alternative Physiological Transfusion Triggers, Anemia, Blood Transfusion, Cancer, Hemoglobin

Keywords

anemia, red blood cell transfusion, physiologic transfusion trigger, alternative transfusion trigger, oxygen extraction ratio, central venous oxygen saturation

Brief summary

This is a prospective, single-center observational study conducted at the Kazakh Institute of Oncology and Radiology. The study included 107 clinically stable adult patients with cancer who required red blood cell transfusion based on a restrictive hemoglobin threshold. The aim of the study was to evaluate alternative physiological indicators of transfusion need and effectiveness. Measurements included oxygen extraction ratio (O₂ER), central venous oxygen saturation (ScvO₂), partial pressure of oxygen in central venous blood (PvO₂), arterio-venous oxygen difference (A-VO₂diff), lactate, and veno-arterial carbon dioxide difference (ΔCO₂). These parameters were assessed before and one hour after transfusion. For data analysis, patients were stratified into two groups based on their baseline O₂ER (≤35.4% and \>35.4%) to evaluate whether higher O₂ER is associated with more pronounced physiological response to transfusion.

Interventions

PROCEDURERed blood cell transfusion

Standard red blood cell transfusion performed as part of routine clinical care. All participants received one or more units of RBCs based on a restrictive hemoglobin threshold. The transfusion protocol was not altered for the purpose of the study.

Sponsors

Ardak Arynov
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult cancer patients (age 18 years or older) * Hemodynamically stable * Not requiring any form of respiratory support * Presence of a central venous catheter inserted into the superior vena cava

Exclusion criteria

* Hemodynamic instability requiring inotropic or vasopressor support * Active bleeding * Shock of any etiology * Patient refusal to participate in the study * Hematological malignancies * Age under 18 years * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Oxygen Extraction Ratio (O₂ER)Baseline and 1 hour post-transfusionDifference in oxygen extraction ratio measured before and one hour after red blood cell transfusion

Secondary

MeasureTime frameDescription
Change in Partial Pressure of Oxygen in Central Venous Blood (PvO₂)Baseline and 1 hour post-transfusionDifference in PvO₂ measured before and one hour after transfusion
Change in Central Venous Oxygen Saturation (ScvO₂)Baseline and 1 hour post-transfusionDifference in ScvO₂ measured before and one hour after transfusion
Change in Lactate ConcentrationBaseline and 1 hour post-transfusionDifference in serum lactate measured before and one hour after transfusion
Change in Arterio-Venous Oxygen Difference (A-VO₂diff)Baseline and 1 hour post-transfusionDifference in arteriovenous oxygen difference measured before and one hour after transfusion
Change in Veno-Arterial Carbon Dioxide Difference (ΔCO₂)Baseline and 1 hour post-transfusionDifference in ΔCO₂ measured before and one hour after transfusion

Countries

Kazakhstan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026